Brazil’s medtech sector is experiencing a fairly powerful transformation, quickly becoming one of the most dynamic and innovative in Latin America. In fact, in 2025, the country is now home to a new generation of health-focused startups that are reshaping how healthcare is delivered, accessed and managed.
From AI-driven diagnostics and remote monitoring tools to digital health records and patient-centred platforms, these startups are combining cutting-edge technology with deep local insight to address Brazil’s unique healthcare challenges. What sets the Brazilian medtech ecosystem apart is its ability to blend scale with social impact – indeed, many of these companies are building solutions that not only improve efficiency but also expand access to care in underserved communities.
Backed by world-class research institutions, rising investment and an increasingly tech-savvy population, Brazil’s medtech future looks bright. In the midst of the industry’s clear resurgence, we’re going to highlight eight standout medtech startups that are making waves in 2025 – companies that are not just innovating for today, but helping to shape the future of healthcare across the region and beyond.
The Transformation of Brazilian MedTech
Over the past decade, Brazil’s medtech industry has evolved from what was once a slow-moving, institution-heavy sector into a vibrant hub for healthcare innovation. This shift has been driven in part by the growing accessibility of digital infrastructure, the rise of private health investment as well as the country’s urgent need to modernise an overstretched public health system.
Startups have stepped in to fill the gap, offering everything from AI-powered diagnostics to telemedicine platforms tailored for Brazil’s vast geography. What was once a fragmented ecosystem has become increasingly structured, with more incubators, accelerators and health-focused venture capital backing promising new ventures.
Regulatory bodies have also made strides toward supporting innovation, although there’s no doubt about the fact navigating healthcare compliance remains a challenge. Importantly, many Brazilian medtech startups are grounded in social purpose, creating scalable technologies that improve health outcomes across socioeconomic boundaries.
Top 8 MedTech Startups in Brazil 2025
With all that in mind, we’re going to have a look at eight of the top medtech startups in Brazil in 2025.
NeoMed
Founded in 2016 in São Paulo by Gustavo Kuster, Izabelle Ferreira, and Bruno de Souza, Neomed blends AI with clinical expertise to overhaul cardiovascular diagnostics. Its platform (Octopus and Kardia) delivers rapid ECG and ECG-like exam reports, often within 24 hours, dramatically reducing wait times and cutting costs by up to 60%.
Joining Google for Startups Accelerator helped accelerate its AI capabilities, and it now serves more than 150 different clinics and hospitals. Success stems from solving a critical pain point in emergent cardiology and expanding access outside major cities. With plans to expand across Latin America and evolve its AI diagnostics toolkit, Neomed is on track to become a global leader in medtech.
BloomCare
BloomCare focuses on digital care platforms geared towards women’s and family medicine. Launched in 2017 in São Paulo by a team with a passion for family health, BloomCare automates appointment scheduling, maternal health tracking, follow‑ups and patient records, all through an empathetic, user-friendly interface.
Its early traction has come from private clinics and health systems looking to modernise perinatal and women’s health services. BloomCare stands out by combining tech innovation with compassionate care design. Future growth looks promising as it expands into telemedicine, wellness ecosystems and broader health monitoring solutions.
Tietê Agroindustrial
Based in Piracicaba, São Paulo, Tietê Agroindustrial began as an agritech innovator but has branched into medtech by developing biosensors used in occupational health monitoring. Founded in 2013 by agricultural engineers making a move toward healthcare, the company now supplies sensor‑driven systems to monitor worker exposure and wellness in industrial settings.
Its success lies in offering rugged, reliable hardware combined with cloud-based analytics that serve both agribusiness and healthcare compliance needs. As workplace safety gains prominence in Brazil, Tietê is expanding its platform to monitor chronic conditions and deliver preventive health alerts, potentially translating its model into healthcare clinics and public health initiatives.
Pharmalens
Founded in 2018 in Belo Horizonte by pharmaceutical researchers and AI engineers, Pharmalens leverages computer vision and machine learning to automate quality control in biotech manufacturing. Its core solution digitises lab workflows, allowing automated cell counting and contaminant detection in biopharma processes.
This automation has reduced error rates significantly and cut lab costs dramatically, resulting in adoption in both research institutes and contracted manufacturing facilities. Pharmalens’s blend of lab‑grade accuracy and pipeline automation has driven its success. Looking forward, the company plans to apply its imaging platform to diagnostics (like blood analysis) and expand across Latin America’s biotech sector
Biomedical
Launched in Rio de Janeiro in 2019, Biomedical was founded by a team of pathologists and software developers aiming to democratise remote diagnostics. Their SaaS platform enables image-based telepathology, allowing doctors to remotely review histology and cytology slides via secure cloud access.
Success has come from fulfilling a clear clinical gap – that is, specialist access in underserved regions. Biomedical’s platform integrates seamlessly with existing lab hardware and offers fast turnaround, appealing to regional hospitals. As it grows, the company plans to incorporate AI-assisted screening and expand into remote radiology and dermatopathology, positioning itself as a comprehensive tele-diagnostic provider for emerging markets.
M3DIC Healthcare Technologies
Established in Natal in 2018 by biomedical engineers, M3DIC’s flagship device, Venoscópio, uses near-infrared imaging to visualise veins and guide venipuncture. The device significantly reduces failed attempts, especially in paediatric and geriatric care, improving patient comfort while optimising nurse time.
The portability and clinical accuracy of Venoscópio have secured contracts with major hospitals across Brazil. M3DIC’s lean hardware model and strong clinician feedback loop underpin its success. By 2025, the startup seeks to integrate its device into broader point‑of‑care AI platforms and to secure export channels into Latin America and Africa, enhancing vascular access solutions globally.
Dr. AI
Founded in Brasília in 2020 by a team of GPs and data scientists, Dr. AI offers a conversational AI platform for preliminary symptom triage and virtual health consultations. Accessible via web and mobile, it uses natural language processing to assess symptoms and deliver advice, helping patients decide whether to seek in‑person care.
It has gained popularity in both urban and remote regions, alleviating pressure on public health systems. Dr. AI stands out for culturally adapted language models and integration with local telemedicine providers. Futuristically, the startup plans to expand its health modules (adding mental health and chronic disease management) and pursue partnerships with government health services to enhance virtual primary care access.
Tato Fisioterapia Inteligente
Founded in São Paulo in 2019 by physiotherapists and digital health entrepreneurs, Tato Fisioterapia Inteligente specialises in AI‑powered rehabilitation. Its platform merges remote triage, guided exercise programmes, and tele‑rehab tools to manage musculoskeletal conditions and chronic pain.
Clients include health insurance companies and occupational health departments that benefit from lower care costs and scalable patient support. Tato’s success stems from combining evidence‑based physiotherapy protocols with intuitive digital delivery and real‑time progress tracking. In 2025, it extends its offerings by integrating wearables and predictive analytics to personalise rehabilitation pathways, potentially expanding across Latin America’s corporate healthcare networks.
